Medpace Holdings (MEX:MEDP) E10: MXN98.52 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MEDP Medpace Holdings Inc MEX:MEDP
95 GF Score
Price MXN7,022.03
GF Value MXN6,131.53
! 2 Warning Signs
View Full Analysis

What is Medpace Holdings E10?

Medpace Holdings MEX:MEDP 95 E10 is MXN98.52 as of Jun. 2026. GuruFocus rates MEX:MEDP with a GF Score™ of 95/100 and a GF Value™ of MXN6,131.53. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medpace Holdings's adjusted earnings per share data for the three months ended in Jun. 2026 was MXN74.158. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN98.52 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Medpace Holdings's average E10 Growth Rate was 35.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-25), Medpace Holdings's current stock price is MXN7022.03. Medpace Holdings's E10 for the quarter that ended in Jun. 2026 was MXN98.52. Medpace Holdings's Shiller PE Ratio of today is 71.28.

During the past 13 years, the highest Shiller PE Ratio of Medpace Holdings was 107.52. The lowest was 55.86. And the median was 75.49.


Medpace Holdings  (MEX:MEDP) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medpace Holdings's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=7022.03/98.52
=71.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Medpace Holdings was 107.52. The lowest was 55.86. And the median was 75.49.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medpace Holdings E10 Related Terms


Medpace Holdings E10 Historical Data

* Premium members only.

The historical data trend for Medpace Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medpace Holdings E10 Chart

Medpace Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 101.73 67.00

Medpace Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.85 67.70 67.00 84.98 98.52

MEX:MEDP vs ICLR, RVTY, CRL: E10 Comparison

For the Diagnostics & Research subindustry, Medpace Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medpace Holdings Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Shiller PE Ratio falls into.


MEX:MEDP
95GF Score
Medpace Holdings Inc MEX:MEDP
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medpace Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medpace Holdings's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=74.158/333.9520*333.9520
=74.158

Current CPI (Jun. 2026) = 333.9520.

Medpace Holdings Quarterly Data

per share eps CPI Adj_EPS
201609 2.514 241.428 3.477
201612 -0.011 241.432 -0.015
201703 3.766 243.801 5.159
201706 4.157 244.955 5.667
201709 4.537 246.819 6.139
201712 5.892 246.524 7.982
201803 7.267 249.554 9.725
201806 8.842 251.989 11.718
201809 9.727 252.439 12.868
201812 11.977 251.233 15.920
201903 9.893 254.202 12.997
201906 14.022 256.143 18.281
201909 12.437 256.759 16.176
201912 14.711 256.974 19.118
202003 17.820 258.115 23.056
202006 14.773 257.797 19.137
202009 24.079 260.280 30.895
202012 26.854 260.474 34.429
202103 23.303 264.877 29.380
202106 21.100 271.696 25.935
202109 26.525 274.310 32.292
202112 27.078 278.802 32.434
202203 33.650 287.504 39.086
202206 29.372 296.311 33.103
202209 41.236 296.808 46.396
202212 41.332 296.797 46.506
202303 40.917 301.836 45.271
202306 33.088 305.109 36.216
202309 38.670 307.789 41.957
202312 41.757 306.746 45.461
202403 53.108 312.332 56.784
202406 50.380 314.175 53.551
202409 59.268 315.301 62.774
202412 76.540 315.605 80.989
202503 75.082 319.799 78.405
202506 58.371 322.561 60.432
202509 70.809 324.800 72.804
202512 84.087 324.054 86.655
202603 77.180 330.213 78.054
202606 74.158 333.952 74.158

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN98.52 mean?
Medpace Holdings (MEX:MEDP) has a E10 of MXN98.52 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medpace Holdings and its competitors.
Is Medpace Holdings' E10 too high?
Medpace Holdings' current E10 is MXN98.52. Overall, Medpace Holdings has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Medpace Holdings' E10 compare to ICLR and RVTY?
Medpace Holdings' E10 of MXN98.52 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medpace Holdings and its competitors. Medpace Holdings's current E10 is MXN98.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medpace Holdings stock overvalued right now?
Medpace Holdings (MEX:MEDP) has a current E10 of MXN98.52. The stock's GF Value™ is MXN6,131.53, compared to a current price of MXN7,022.03 — trading 14.5% above its estimated fair value. The current E10 is MXN98.52. Medpace Holdings' overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Medpace Holdings (MEX:MEDP), the current E10 is MXN98.52 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medpace Holdings (MEX:MEDP) Overvalued in 2026?

Based on GuruFocus' analysis, Medpace Holdings stock appears to be overvalued. The current stock price of MXN7,022.03 is trading 14.5% above its estimated GF Value™ of MXN6,131.53.

Key valuation signals for MEX:MEDP:

  • E10: MXN98.52
  • GF Value™: MXN6,131.53 vs. price of MXN7,022.03 (14.5% above fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the MEX:MEDP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medpace Holdings Business Description

Other Exchanges MEDP:USA01P:Germany
Address 5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
95GF Score

Get the complete analysis for MEX:MEDP

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN7,022.03
Price
MXN6,131.53
GF Value